Teicoplanin: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages | {{subpages}} | ||
In [[medicine]] and [[pharmacology]], '''teicoplanin''' is a "[[glycopeptide antibiotic]] complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety."<ref>{{MeSH}}</ref><ref name="pmid15750036">{{cite journal |author=Finch RG, Eliopoulos GM |title=Safety and efficacy of glycopeptide antibiotics |journal=J. Antimicrob. Chemother. |volume=55 Suppl 2 |issue= |pages=ii5–13 |year=2005 |month=March |pmid=15750036 |doi=10.1093/jac/dki004 |url=http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15750036 |issn=}}</ref> | In [[medicine]] and [[pharmacology]], '''teicoplanin''' is a "[[glycopeptide antibiotic]] complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety."<ref>{{MeSH}}</ref><ref name="pmid15750036">{{cite journal |author=Finch RG, Eliopoulos GM |title=Safety and efficacy of glycopeptide antibiotics |journal=J. Antimicrob. Chemother. |volume=55 Suppl 2 |issue= |pages=ii5–13 |year=2005 |month=March |pmid=15750036 |doi=10.1093/jac/dki004 |url=http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15750036 |issn=}}</ref> | ||
Revision as of 18:04, 31 January 2009
In medicine and pharmacology, teicoplanin is a "glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety."[1][2]
Other glycopeptide antibiotics include vancomycin and dalbavancin.
Teicoplanin can be used to treat pseudomembranous enterocolitis due to Clostridium difficile.[3]
References
- ↑ Anonymous (2024), Teicoplanin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Finch RG, Eliopoulos GM (March 2005). "Safety and efficacy of glycopeptide antibiotics". J. Antimicrob. Chemother. 55 Suppl 2: ii5–13. DOI:10.1093/jac/dki004. PMID 15750036. Research Blogging.
- ↑ Smith GC (April 1995). "What can consultation-liaison psychiatry contribute to psychosomatic research?". J Psychosom Res 39 (3): 247–50. PMID 7636768. [e]